trial

Neurocognition After Perturbed Sleep

NCTId NCT05032963
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 28 (actual)
Sponsored by Icahn School of Medicine at Mount Sinai
Primary completion 2024-05-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
28 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Single
Start
2021-09-21
Primary completion
2024-05-31
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Overnight polysomnography examinations

Sponsors

Icahn School of Medicine at Mount SinaiLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
David Kimhy, PhDPrincipal Investigator

Sites

1 total
New York, United States

Facts & assertions

4 sourced
Enrollment
28
Phase
NA
Primary Completion Date
2024-05-31
Status
COMPLETED
relationships
The graph out of here
drug
Overnight polysomnography examinations
drug
lead_sponsor
Icahn School of Medicine at Mount Sinai
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizophrenia
indication
Emotional Regulation
indication
investigator
David Kimhy, PhD
person